Fibrinogen and high-sensitive C-reactive protein as serologic predictors for perioperative cerebral microembolic lesions after carotid endarterectomy

Journal of Vascular Surgery

Volumn 46, Issue 3, 2007, Pages 449-454

  Heider, Peter ^a   Poppert, Holger ^a   Wolf, Oliver ^a   Liebig, Thomas ^a   Pelisek, Jaroslav ^a   Schuster, Tibor ^a   Eckstein, Hans H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BRAIN EMBOLISM; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEROLOGY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; MALE; NEPHELOMETRY AND TURBIDIMETRY; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 34548435521     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.05.035     Document Type: Article

References (25)

1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 (1991) 445-453
2. Wolf O., Heider P., Heinz M., Poppert H., Schmidt-Thieme T., Sander D., et al. Frequency, clinical significance and course of cerebral ischemic events after carotid endarterectomy evaluated by serial diffusion weighted imaging. Eur J Vasc Endovasc Surg 27 (2004) 167-171
3. Bots M.L., Elwood P.C., Salonen J.T., de Freire C., Sivenius J., Di Carlo A., et al. Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 56 (2002) i14-i18
4. Kofoed S.C., Wittrup H.H., Sillesen H., and Nordestgaard B.G. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur Heart J 24 (2003) 567-576
5. Dosa E., Rugonfalvi-Kiss S., Prohaszka Z., Szabo A., Karadi I., Selmeci L., et al. Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflamm Res 53 (2004) 631-635
6. Maresca G., Di Blasio A., Marchioli R., and Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 19 (1999) 1368-1377
7. Bini A., and Kudryk B.J. Fibrin and its derivatives in the normal and diseased vessel wall. Ann N Y Acad Sci 667 (1992) 112-126
8. Mauriello A., Sangiorgi G., Palmieri G., Virmani R., Holmes Jr. D.R., Schwartz R.S., et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 101 (2000) 744-750
9. Pai J.K., Curhan G.C., Cannuscio C.C., Rifai N., Ridker P.M., and Rimm E.B. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 48 (2002) 1781-1784
10. Kondo K., Kitagawa K., Nagai Y., Yamagami H., Hashimoto H., Hougaku H., et al. Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis 179 (2005) 155-160
11. Rerkasem K., Shearman C.P., Williams J.A., Morris G.E., Phillips M.J., Calder P.C., et al. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg 23 (2002) 505-509
12. Choi H., Cho D.H., Shin H.H., and Park J.B. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 68 (2004) 297-303
13. Jahn J., Hellmann I., Maass M., Giannitsis E., Dalhoff K., and Katus H.A. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome. Herz 29 (2004) 795-801
14. Alvarez G.B., Ruiz C., Chacon P., Sabin J.A., and Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 38 (2003) 1018-1024
15. Zwaka T.P., Hombach V., and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103 (2001) 1194-1197
16. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
17. Hashimoto H., Kitagawa K., Hougaku H., Shimizu Y., Sakaguchi M., Nagai Y., et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 104 (2001) 63-67
18. Tanne D., Benderly M., Goldbourt U., Haim M., Tenenbaum A., Fisman E.Z., et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 37 (2006) 1720-1724
19. Ma J., Hennekens C.H., Ridker P.M., and Stampfer M.J. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol 33 (1999) 1347-1352
20. Coppola G., Rizzo M., Abrignani M.G., Corrado E., Di Girolamo A., Braschi A., et al. Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study. Ital Heart J 6 (2005) 315-322
21. Gonzalez-Conejero R., Fernandez-Cadenas I., Iniesta J.A., Marti-Fabregas J., Obach V., Alvarez-Sabin J., et al. Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke 37 (2006) 2288-2293
22. Di Napoli M., Papa F., and Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32 (2001) 133-138
23. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
24. Levenson J., Giral P., Razavian M., Gariepy J., and Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 15 (1995) 1263-1268
25. Sethi A.A., Tybjaerg-Hansen A., Gronholdt M.L., Steffensen R., Schnohr P., and Nordestgaard B.G. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 134 (2001) 941-954